Business
Q1 Tradng Update
Q1 Tradng Update.
About this update from Reckitt Benckiser Group Plc
[{"type":"text","content":"\n \nRNS Number : 8197X Reckitt Benckiser Group PLC 02 May 2019 \n\n \n \n02 May 2019 \n \nON TRACK FOR FULL-YEAR TARGETS\nQ1 2019 Trading Update\n \n \n\n\n\n\n\n\nQ1\n \n\n\n\n\n\n\n\n£m\n\n\nLFL1\n \n\n\nFX\n\n\nReported\n \n\n\n\n\nIFCN\n\n\n758\n\n\n+5%\n\n\n+3%\n\n\n+8%\n\n\n\n\nOTC\n\n\n470\n\n\n-9%\n\n\n0%\n\n\n-9%\n\n\n\n\nOther\n\n\n707\n\n\n0%\n\n\n+1%\n\n\n+1%\n\n\n\n\nTotal Health\n \n\n\n1,935\n\n\n0%\n\n\n+1%\n\n\n+1%\n\n\n\n\nHygiene Home\n \n\n\n1,222\n\n\n+3%\n\n\n-1%\n\n\n+2%\n\n\n\n\nTotal\n\n\n3,157\n\n\n+1%\n\n\n0%\n\n\n+1%\n\n\n\n \n \n \n\n\n\nHighlights \n· LFL growth in Q1 of +1%. Continuing momentum in Hygiene Home. Slow start in Health as expected. \n· LFL performance in Total Health was flat. Progress in IFCN USA and China was offset by seasonal weakness in OTC and a mixed result from Other (Wellness and Health Hygiene) brands. \n· LFL growth in Hygiene Home of +3%. Continued momentum with strong performances from Finish, Vanish and Harpic. \n· We remain on track for the full year net revenue target of +3-4% LFL with growth to be H2 weighted.\n· RB2.0 remains on track.\n\n\n\n \nCommenting on these results, Rakesh Kapoor, Chief Executive Officer, said: \n\"As expected, Q1 saw a slow start to the year, especially in OTC. We expect to see improving growth in the remainder of the year, particularly in H2. \nOur health business unit (BU) was impacted by the unusually weak cold and flu season across US and several European markets and associated retailer inventory movements. While our seasonal products declined, Nurofen and Gaviscon delivered good growth from a combination of recent innovations and quality base products. Our IFCN business delivered a good Q1 (+5%), with innovation led momentum continuing in the US and further progress in China. \nE-comm...